AstraZeneca is scaling up releases of Covid-19 vaccine doses to the United Kingdom to the point where it expects to be providing 2 million a week by or before the middle of February, a top executive told lawmakers on Wednesday.
“We’ve released just over 1.1 million doses, to date, and we are scaling up as we’ve said very rapidly. And this will happen imminently, to releasing 2 million doses a week; we’re absolutely on track to do that,” said Tom Keith-Roach, president of AstraZeneca UK.
“We’re scaling up to 2 million a week imminently, and certainly we hope to be there on or before the middle of February,” he said.
Meanwhile, India has authorised the emergency use of two coronavirus vaccines developed by AstraZeneca and Oxford University; and also by local pharmaceutical firm Bharat Biotech, according to the country’s drug regulator.
At a news briefing on Sunday, Drugs Controller General Dr Venugopal G Somani said both vaccines would be administered in two doses.
“The… vaccines of Serum Institute [AstraZeneca-Oxford vaccine] and Bharat Biotech are being approved for restricted use in emergency situations;” Somani said, referring to the Indian firm that manufactured the former vaccine.
Prime Minister Narendra Modi tweeted that the fast-track approvals were “a decisive turning point to strengthen a spirited fight;” that “accelerates the road to a healthier and COVID-free nation”.